Moderna is counting on a turnover of 17 billion euros this year

Biotechnology company Moderna expects to earn more money from its corona vaccine this year than previously reported. The company raised its sales forecast for the vaccine in a trade update aided by the company’s efforts to ramp up production after last year’s manufacturing difficulties. Moderna expects a turnover of 19 billion dollars for the entire year, or 17 billion euros.

ttn-3